156 related articles for article (PubMed ID: 11463838)
1. Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome.
Nekrep N; Geyer M; Jabrane-Ferrat N; Peterlin BM
Mol Cell Biol; 2001 Aug; 21(16):5566-76. PubMed ID: 11463838
[TBL] [Abstract][Full Text] [Related]
2. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
3. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
[TBL] [Abstract][Full Text] [Related]
5. Mutation and modeling analysis of the Saccharomyces cerevisiae Swi6 ankyrin repeats.
Ewaskow SP; Sidorova JM; Hendle J; Emery JC; Lycan DE; Zhang KY; Breeden LL
Biochemistry; 1998 Mar; 37(13):4437-50. PubMed ID: 9521763
[TBL] [Abstract][Full Text] [Related]
6. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
Nekrep N; Jabrane-Ferrat N; Peterlin BM
Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
[TBL] [Abstract][Full Text] [Related]
8. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
Dziembowska M; Fondaneche MC; Vedrenne J; Barbieri G; Wiszniewski W; Picard C; Cant AJ; Steimle V; Charron D; Alca-Loridan C; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional silencing of RFXAP in MHC class II-deficiency.
van Eggermond MC; Tezcan I; Heemskerk MH; van den Elsen PJ
Mol Immunol; 2008 May; 45(10):2920-8. PubMed ID: 18336911
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of the Bare lymphocyte syndrome.
Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
[TBL] [Abstract][Full Text] [Related]
11. Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.
Wang AH; Grégoire S; Zika E; Xiao L; Li CS; Li H; Wright KL; Ting JP; Yang XJ
J Biol Chem; 2005 Aug; 280(32):29117-27. PubMed ID: 15964851
[TBL] [Abstract][Full Text] [Related]
12. Associations and interactions between bare lymphocyte syndrome factors.
DeSandro AM; Nagarajan UM; Boss JM
Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.
Yuan C; Li J; Mahajan A; Poi MJ; Byeon IJ; Tsai MD
Biochemistry; 2004 Sep; 43(38):12152-61. PubMed ID: 15379554
[TBL] [Abstract][Full Text] [Related]
14. Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally?
Bork P
Proteins; 1993 Dec; 17(4):363-74. PubMed ID: 8108379
[TBL] [Abstract][Full Text] [Related]
15. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
[TBL] [Abstract][Full Text] [Related]
16. A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review.
Cai YQ; Zhang H; Wang XZ; Xu C; Chao YQ; Shu Y; Tang LF
Open Forum Infect Dis; 2020 Aug; 7(8):ofaa314. PubMed ID: 32875002
[TBL] [Abstract][Full Text] [Related]
17. Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK.
McKinsey TA; Kuwahara K; Bezprozvannaya S; Olson EN
Mol Biol Cell; 2006 Jan; 17(1):438-47. PubMed ID: 16236793
[TBL] [Abstract][Full Text] [Related]
18. Ankyrin repeat: a unique motif mediating protein-protein interactions.
Li J; Mahajan A; Tsai MD
Biochemistry; 2006 Dec; 45(51):15168-78. PubMed ID: 17176038
[TBL] [Abstract][Full Text] [Related]
19. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.
Waldburger JM; Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Landmann S; Reith W
Immunol Rev; 2000 Dec; 178():148-65. PubMed ID: 11213800
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
